apace drugs dr firm listed europe big short continuing competition annoucement anti decrease whose well december bn known manufacturers exclusive maker spending flagged strength another rights court new banning generics marketing selling representing r although india product opportunity case launches hypertension producing fell number slide face famous business pharmaceutical shares name key sale pfizer future versions cause company lost indian rose built staple also fall pressures home norvasc drug due months profits prozac sales recent ingredients us gathering drugmaker generic costs said alongside lilly york march heavy reputation strong patents three rising near reddy products development intensified depressant competitors version competitive run previous poorly popular rupees eli performed research year